# The Antidepressant Efficacy of the Anticholinergic Scopolamine

> **NCT00369915** · PHASE2 · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 17 (actual)

## Conditions studied

- Unipolar Depression
- Bipolar Depression

## Interventions

- **DRUG:** Scopolamine
- **DRUG:** Scopolamine

## Key facts

- **NCT ID:** NCT00369915
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369915, "The Antidepressant Efficacy of the Anticholinergic Scopolamine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00369915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*